Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kynurenine | 16 | 2020 | 36 | 5.140 |
Why?
|
| Kynurenic Acid | 16 | 2021 | 26 | 3.750 |
Why?
|
| Prenatal Exposure Delayed Effects | 8 | 2021 | 154 | 2.530 |
Why?
|
| Memory | 7 | 2020 | 214 | 1.840 |
Why?
|
| Schizophrenia | 11 | 2020 | 206 | 1.680 |
Why?
|
| Hippocampus | 7 | 2018 | 471 | 1.540 |
Why?
|
| Wakefulness | 2 | 2021 | 75 | 1.350 |
Why?
|
| Sleep Wake Disorders | 2 | 2021 | 94 | 1.280 |
Why?
|
| Sleep | 3 | 2022 | 263 | 1.090 |
Why?
|
| Rats, Wistar | 10 | 2021 | 371 | 1.080 |
Why?
|
| Memory Disorders | 2 | 2018 | 111 | 1.030 |
Why?
|
| Psychotic Disorders | 4 | 2021 | 157 | 1.010 |
Why?
|
| Brain | 11 | 2020 | 2176 | 1.000 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2009 | 140 | 0.990 |
Why?
|
| Sex Characteristics | 3 | 2021 | 295 | 0.920 |
Why?
|
| Cognition | 7 | 2018 | 513 | 0.910 |
Why?
|
| Apolipoproteins E | 4 | 2009 | 92 | 0.800 |
Why?
|
| Sleep Stages | 1 | 2021 | 30 | 0.790 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2018 | 11 | 0.770 |
Why?
|
| Rats | 16 | 2022 | 5300 | 0.760 |
Why?
|
| Transaminases | 2 | 2018 | 21 | 0.760 |
Why?
|
| Thiazolidinediones | 2 | 2018 | 77 | 0.740 |
Why?
|
| Spatial Learning | 1 | 2020 | 12 | 0.730 |
Why?
|
| Cognition Disorders | 3 | 2017 | 342 | 0.730 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2018 | 381 | 0.690 |
Why?
|
| Animals | 29 | 2022 | 20881 | 0.670 |
Why?
|
| Sleep Deprivation | 2 | 2022 | 81 | 0.650 |
Why?
|
| Glutamic Acid | 5 | 2018 | 332 | 0.560 |
Why?
|
| Behavior | 1 | 2016 | 59 | 0.520 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 65 | 0.520 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 50 | 0.500 |
Why?
|
| Pregnancy | 9 | 2021 | 2334 | 0.490 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 176 | 0.480 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 2 | 2009 | 9 | 0.410 |
Why?
|
| Maze Learning | 7 | 2014 | 138 | 0.390 |
Why?
|
| Microglia | 2 | 2009 | 143 | 0.380 |
Why?
|
| Male | 21 | 2021 | 37321 | 0.380 |
Why?
|
| Tryptophan | 3 | 2020 | 65 | 0.370 |
Why?
|
| Cytokines | 3 | 2020 | 866 | 0.340 |
Why?
|
| Receptors, LDL | 2 | 2009 | 72 | 0.340 |
Why?
|
| Neuroglia | 1 | 2009 | 136 | 0.320 |
Why?
|
| Age Factors | 5 | 2018 | 1864 | 0.320 |
Why?
|
| Schizophrenic Psychology | 2 | 2017 | 53 | 0.290 |
Why?
|
| Female | 19 | 2022 | 38074 | 0.290 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 2550 | 0.250 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 565 | 0.230 |
Why?
|
| Signal Transduction | 3 | 2020 | 2689 | 0.230 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1293 | 0.220 |
Why?
|
| Inflammation | 1 | 2009 | 1030 | 0.210 |
Why?
|
| Electroencephalography | 2 | 2022 | 418 | 0.210 |
Why?
|
| Eye Movements | 1 | 2022 | 44 | 0.200 |
Why?
|
| Sleep, REM | 1 | 2021 | 93 | 0.190 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 3 | 2016 | 9 | 0.190 |
Why?
|
| Electromyography | 1 | 2021 | 184 | 0.190 |
Why?
|
| Estradiol | 1 | 2022 | 176 | 0.190 |
Why?
|
| Diet, Gluten-Free | 1 | 2020 | 4 | 0.180 |
Why?
|
| Mice | 9 | 2017 | 8474 | 0.170 |
Why?
|
| Stress, Psychological | 2 | 2018 | 824 | 0.170 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2016 | 266 | 0.170 |
Why?
|
| Saliva | 2 | 2018 | 142 | 0.170 |
Why?
|
| Animals, Newborn | 2 | 2012 | 396 | 0.170 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 659 | 0.160 |
Why?
|
| Corticosterone | 1 | 2018 | 51 | 0.150 |
Why?
|
| Brain Stem | 1 | 2017 | 46 | 0.150 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 415 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2020 | 434 | 0.150 |
Why?
|
| Gyrus Cinguli | 1 | 2018 | 113 | 0.150 |
Why?
|
| Kynurenine 3-Monooxygenase | 1 | 2016 | 1 | 0.140 |
Why?
|
| Placenta | 1 | 2017 | 101 | 0.140 |
Why?
|
| Locomotion | 1 | 2017 | 135 | 0.140 |
Why?
|
| Brain Injuries | 2 | 2011 | 268 | 0.140 |
Why?
|
| Behavior, Animal | 3 | 2014 | 470 | 0.140 |
Why?
|
| Depressive Disorder | 2 | 2018 | 621 | 0.130 |
Why?
|
| Time Factors | 4 | 2014 | 4655 | 0.130 |
Why?
|
| Clozapine | 2 | 2006 | 46 | 0.130 |
Why?
|
| Microdialysis | 2 | 2014 | 147 | 0.130 |
Why?
|
| Cells, Cultured | 3 | 2009 | 2673 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2014 | 2083 | 0.120 |
Why?
|
| Tissue Distribution | 1 | 2014 | 282 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 1174 | 0.110 |
Why?
|
| Avoidance Learning | 1 | 2014 | 58 | 0.110 |
Why?
|
| Antipsychotic Agents | 2 | 2006 | 247 | 0.110 |
Why?
|
| Galantamine | 1 | 2013 | 9 | 0.110 |
Why?
|
| Nootropic Agents | 1 | 2013 | 18 | 0.110 |
Why?
|
| Spatial Behavior | 1 | 2012 | 18 | 0.100 |
Why?
|
| Electrochemical Techniques | 1 | 2012 | 23 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2009 | 954 | 0.100 |
Why?
|
| Extracellular Fluid | 1 | 2011 | 29 | 0.100 |
Why?
|
| Depression | 1 | 2018 | 943 | 0.100 |
Why?
|
| Humans | 13 | 2020 | 68618 | 0.100 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2011 | 5 | 0.100 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2011 | 5 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 640 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2009 | 791 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 120 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2011 | 141 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.090 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 6 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 1 | 2011 | 191 | 0.080 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 1 | 2009 | 1 | 0.080 |
Why?
|
| Chimera | 1 | 2009 | 33 | 0.080 |
Why?
|
| Dehydroepiandrosterone | 1 | 2009 | 29 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 181 | 0.080 |
Why?
|
| Attention | 3 | 2017 | 225 | 0.080 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 59 | 0.080 |
Why?
|
| Peptides | 2 | 2009 | 455 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2009 | 201 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2009 | 289 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2009 | 382 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 455 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2009 | 176 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 331 | 0.070 |
Why?
|
| Receptors, Nicotinic | 1 | 2006 | 41 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2006 | 115 | 0.070 |
Why?
|
| Fornix, Brain | 1 | 2005 | 5 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2005 | 79 | 0.060 |
Why?
|
| Neurons | 2 | 2006 | 881 | 0.060 |
Why?
|
| Adult | 5 | 2020 | 21403 | 0.050 |
Why?
|
| Biomarkers | 2 | 2020 | 1593 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1664 | 0.050 |
Why?
|
| Gliadin | 1 | 2020 | 5 | 0.050 |
Why?
|
| Motor Activity | 2 | 2016 | 621 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 27 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 5717 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 481 | 0.040 |
Why?
|
| Dextroamphetamine | 1 | 2016 | 30 | 0.040 |
Why?
|
| Adolescent | 2 | 2020 | 8912 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 1738 | 0.030 |
Why?
|
| Cerebellum | 1 | 2016 | 103 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1342 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 21147 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 492 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 239 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 396 | 0.030 |
Why?
|
| Reversal Learning | 1 | 2014 | 7 | 0.030 |
Why?
|
| Nicotinic Agonists | 2 | 2006 | 111 | 0.030 |
Why?
|
| Dendritic Spines | 1 | 2014 | 76 | 0.030 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2014 | 75 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 102 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2011 | 2791 | 0.030 |
Why?
|
| Exercise | 1 | 2018 | 658 | 0.030 |
Why?
|
| Nicotine | 2 | 2006 | 350 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 1692 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 517 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2011 | 13 | 0.020 |
Why?
|
| Liver X Receptors | 1 | 2011 | 8 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 514 | 0.020 |
Why?
|
| Microsomes | 1 | 2009 | 31 | 0.020 |
Why?
|
| Ferrous Compounds | 1 | 2009 | 18 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2009 | 47 | 0.020 |
Why?
|
| Testosterone | 1 | 2009 | 96 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2011 | 506 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2006 | 4 | 0.020 |
Why?
|
| Receptors, Lipoprotein | 1 | 2006 | 11 | 0.020 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2006 | 5 | 0.020 |
Why?
|
| Aconitine | 1 | 2006 | 5 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2006 | 11 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2006 | 35 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2005 | 8 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 28 | 0.020 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2005 | 15 | 0.020 |
Why?
|
| Endocytosis | 1 | 2006 | 113 | 0.020 |
Why?
|
| Osmosis | 1 | 2005 | 38 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2005 | 43 | 0.020 |
Why?
|
| Exons | 1 | 2005 | 122 | 0.020 |
Why?
|
| COS Cells | 1 | 2005 | 155 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2005 | 59 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 132 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 175 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2005 | 93 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2005 | 155 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2005 | 128 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 322 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2005 | 312 | 0.020 |
Why?
|
| Ligands | 1 | 2005 | 317 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 216 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 525 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 782 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1200 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1027 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1745 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 448 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 981 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 617 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7029 | 0.010 |
Why?
|